Detailed Information

Cited 7 time in webofscience Cited 6 time in scopus
Metadata Downloads

Self-Assembled Nanoconstructs Modified with Amplified Aptamers Inhibited Tumor Growth and Retinal Vascular Hyperpermeability via Vascular Endothelial Growth Factor Capturing

Full metadata record
DC Field Value Language
dc.contributor.authorLee, Jihyun-
dc.contributor.authorLee, Byung Joo-
dc.contributor.authorLee, Yeong Mi-
dc.contributor.authorPark, Hansoo-
dc.contributor.authorKim, Jeong Hun-
dc.contributor.authorKim, Won Jong-
dc.date.available2019-03-08T08:56:42Z-
dc.date.issued2017-05-
dc.identifier.issn1543-8384-
dc.identifier.issn1543-8392-
dc.identifier.urihttps://scholarworks.bwise.kr/cau/handle/2019.sw.cau/4496-
dc.description.abstractHere, nanoconstructs consisting of a DNA- amplified aptamer with a biocompatible polymer backbone for capturing target biomolecules are presented. First, the polymer-DNA nanoconstructs were prepared by hybridization of two complementary single-stranded DNAs that were each conjugated to a dextran polymer backbone. The designed polymer-DNA amplified aptamer nanoconstructs (PA-aNCs) were then prepared by utilizing polymer-DNA nanoconstructs conjugated with an aptamer (PA-NCs) using a rolling circle amplification reaction to amplify the aptamer. These PA-aNCs were successfully applied to alleviate tumor growth and vascular endothelial growth factor (VEGF)induced retinal vascular hyperpermeability in vivo through the highly effective capture of human VEGF as a target molecule. These PA-aNCs could be used as therapeutic agent for anti-VEGF therapy by efficiently capturing human VEGF.-
dc.format.extent9-
dc.language영어-
dc.language.isoENG-
dc.publisherAMER CHEMICAL SOC-
dc.titleSelf-Assembled Nanoconstructs Modified with Amplified Aptamers Inhibited Tumor Growth and Retinal Vascular Hyperpermeability via Vascular Endothelial Growth Factor Capturing-
dc.typeArticle-
dc.identifier.doi10.1021/acs.molpharmaceut.6b00949-
dc.identifier.bibliographicCitationMOLECULAR PHARMACEUTICS, v.14, no.5, pp 1460 - 1468-
dc.description.isOpenAccessN-
dc.identifier.wosid000400633300014-
dc.identifier.scopusid2-s2.0-85018397688-
dc.citation.endPage1468-
dc.citation.number5-
dc.citation.startPage1460-
dc.citation.titleMOLECULAR PHARMACEUTICS-
dc.citation.volume14-
dc.type.docTypeArticle-
dc.publisher.location미국-
dc.subject.keywordAuthoranti-VEGF therapy-
dc.subject.keywordAuthorDNA nanoconstructs-
dc.subject.keywordAuthorpolymer-DNA conjugates-
dc.subject.keywordAuthorantitumor therapy-
dc.subject.keywordAuthorretinal vascular hyperpermeability-
dc.subject.keywordPlusANTI-ANGIOGENIC THERAPY-
dc.subject.keywordPlusDIABETIC-RETINOPATHY-
dc.subject.keywordPlusMACULAR DEGENERATION-
dc.subject.keywordPlusCANCER-
dc.subject.keywordPlusPHARMACOKINETICS-
dc.subject.keywordPlusPEGAPTANIB-
dc.subject.keywordPlusTARGET-
dc.relation.journalResearchAreaResearch & Experimental Medicine-
dc.relation.journalResearchAreaPharmacology & Pharmacy-
dc.relation.journalWebOfScienceCategoryMedicine, Research & Experimental-
dc.relation.journalWebOfScienceCategoryPharmacology & Pharmacy-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of ICT Engineering > School of Integrative Engineering > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Park, Hansoo photo

Park, Hansoo
창의ICT공과대학 (융합공학부)
Read more

Altmetrics

Total Views & Downloads

BROWSE